Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle R Lofwall

Showing results (51-60 of 126) with videos related to

Pageof 13
Sort By:
AJP Reports|December 12, 2017
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal SyndromeNiraj R Chavan, Kristin B Ashford, Amanda T Wiggins, et al.
Drug and Alcohol Dependence|June 12, 2010
Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteersMiriam Z Mintzer, Ryan K Lanier, Michelle R Lofwall, et al.
Psychopharmacology|July 1, 2010
Physical dependence potential of daily tramadol dosing in humansRyan K Lanier, Michelle R Lofwall, Miriam Z Mintzer, et al.
Addiction (Abingdon, England)|March 15, 2011
The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusersLisa S Middleton, Paul A Nuzzo, Michelle R Lofwall, et al.
Drug and Alcohol Dependence|June 13, 2013
Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trialMichelle R Lofwall, Shanna Babalonis, Paul A Nuzzo, et al.
Experimental and Clinical Psychopharmacology|June 13, 2012
Intranasal oxycodone self-administration in non-dependent opioid abusersLisa S Middleton, Michelle R Lofwall, Paul A Nuzzo, et al.
Drug and Alcohol Dependence|April 2, 2017
Buprenorphine physician supply: Relationship with state-level prescription opioid mortalityHannah K Knudsen, Jennifer R Havens, Michelle R Lofwall, et al.
Drug and Alcohol Dependence|September 14, 2019
US physicians' decision-making during buprenorphine-naloxone treatment: Conjoint analyses of dose and office visit adjustments based on patient progressHannah K Knudsen, Michelle R Lofwall, Lewei Allison Lin, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 5, 2006
Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography/mass spectrometryMaria Esther Rodriguez-Rosas, Michelle R Lofwall, Eric C Strain, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2019
Outpatient Parenteral Antimicrobial Therapy Plus Buprenorphine for Opioid Use Disorder and Severe Injection-related InfectionsLaura C Fanucchi, Sharon L Walsh, Alice C Thornton, et al.
Pageof 13

Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
AJP Reports|December 12, 2017
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal SyndromeNiraj R Chavan, Kristin B Ashford, Amanda T Wiggins, et al.
Drug and Alcohol Dependence|June 12, 2010
Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteersMiriam Z Mintzer, Ryan K Lanier, Michelle R Lofwall, et al.
Psychopharmacology|July 1, 2010
Physical dependence potential of daily tramadol dosing in humansRyan K Lanier, Michelle R Lofwall, Miriam Z Mintzer, et al.
Addiction (Abingdon, England)|March 15, 2011
The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusersLisa S Middleton, Paul A Nuzzo, Michelle R Lofwall, et al.
Drug and Alcohol Dependence|June 13, 2013
Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trialMichelle R Lofwall, Shanna Babalonis, Paul A Nuzzo, et al.
Experimental and Clinical Psychopharmacology|June 13, 2012
Intranasal oxycodone self-administration in non-dependent opioid abusersLisa S Middleton, Michelle R Lofwall, Paul A Nuzzo, et al.
Drug and Alcohol Dependence|April 2, 2017
Buprenorphine physician supply: Relationship with state-level prescription opioid mortalityHannah K Knudsen, Jennifer R Havens, Michelle R Lofwall, et al.
Drug and Alcohol Dependence|September 14, 2019
US physicians' decision-making during buprenorphine-naloxone treatment: Conjoint analyses of dose and office visit adjustments based on patient progressHannah K Knudsen, Michelle R Lofwall, Lewei Allison Lin, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 5, 2006
Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography/mass spectrometryMaria Esther Rodriguez-Rosas, Michelle R Lofwall, Eric C Strain, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2019
Outpatient Parenteral Antimicrobial Therapy Plus Buprenorphine for Opioid Use Disorder and Severe Injection-related InfectionsLaura C Fanucchi, Sharon L Walsh, Alice C Thornton, et al.
Pageof 13